Vir Biotechnology (VIR) Change in Receivables (2021 - 2024)
Vir Biotechnology (VIR) reported Change in Receivables of $8.7 million for Q4 2024, up 142.57% on a YoY basis from $3.6 million in Q1 2024, and up 16098.15% sequentially from $54000.0 in Q3 2024.
Vir Biotechnology (VIR) Change in Receivables (2021 - 2024) Analysis & Trends
Vir Biotechnology (VIR) has 4 years of Change in Receivables data on file, last reported at $8.7 million in Q4 2024.
- For the quarter ending Q4 2024, Change in Receivables rose 142.57% year-over-year to $8.7 million; the trailing twelve-month figure through Dec 2024 stood at $6.5 million (up 1052.74% YoY), and the FY2024 full-year result was $6.5 million, up 1052.74% from the prior year.
- Change in Receivables rose to $8.7 million in Q4 2024, from $54000.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $680.1 million in Q4 2021 to a low of -$883.8 million in Q2 2022.
- A 4-year average of $778384.6 and a median of $54000.0 in 2024 frame the typical range for Change in Receivables.
- Peak annual rise in Change in Receivables reached 142.57% in 2024, while the deepest fall reached 183.65% in 2024.
- Tracing VIR's Change in Receivables over 4 years: stood at $680.1 million in 2021, then tumbled by 140.9% to -$278.2 million in 2022, then jumped by 101.3% to $3.6 million in 2023, then surged by 142.57% to $8.7 million in 2024.
- Business Quant data shows VIR's Change in Receivables at $8.7 million in Q4 2024, $54000.0 in Q3 2024, and -$2.7 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Vir Biotechnology | 1.38 Bn | 1.38 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 8.75 Mn |
| Dec 31, 2024 | 8.75 Mn |
| Sep 30, 2024 | 54,000.00 |
| Sep 30, 2024 | 54,000.00 |
| Jun 30, 2024 | -2.69 Mn |
| Jun 30, 2024 | -2.69 Mn |
| Mar 31, 2024 | 401,000.00 |
| Mar 31, 2024 | 401,000.00 |
| Dec 31, 2023 | 3.61 Mn |
| Dec 31, 2023 | 3.61 Mn |
| Jun 30, 2023 | -948,000.00 |
| Jun 30, 2023 | -948,000.00 |
| Mar 31, 2023 | -2.09 Mn |
| Mar 31, 2023 | -2.09 Mn |
| Dec 31, 2022 | -278.17 Mn |
| Dec 31, 2022 | -278.17 Mn |
| Sep 30, 2022 | -58.18 Mn |
| Sep 30, 2022 | -58.18 Mn |
| Jun 30, 2022 | -883.77 Mn |
| Jun 30, 2022 | -883.77 Mn |